HYPERRHO

This brand name is authorized in United States. It is also authorized in Hong Kong SAR China, Singapore, Turkey.

Active ingredients

The drug HYPERRHO contains one active pharmaceutical ingredient (API):

1	Anti-D (rh) immunoglobulin UNII 48W7181FLP - HUMAN RHO(D) IMMUNE GLOBULIN
	Human anti-D immunoglobulin contains specific antibodies (IgG) against the Rh(D) antigen of human erythrocytes. It can also contain antibodies to other Rh antigens, e.g. anti-Rh C antibodies. The mechanism by which anti-D immunoglobulin suppresses immunisation to Rh(D) positive red cells is not known.
	Read more about Anti-D (rh) immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
HYPERRHO S/D FULL DOSE Solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J06BB01	Anti-D (rh) immunoglobulin	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	54494
SG	Health Sciences Authority	09660P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699769980306
US	FDA, National Drug Code	13533-631, 13533-661